Drug Profile
Ephedrine sulfate - Exela Sterile Medicines
Alternative Names: Akovaz; Ephedrine sulfate; UMD 3 - Avadel Pharmaceuticals; UMD#3 - Avadel Pharmaceuticals; Unapproved marketed drug 3 - Avadel Pharmaceuticals; Unapproved marketed drug#3 - Avadel Pharmaceuticals; Undisclosed drug#3 - Avadel Pharmaceuticals; Éclat #3Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Eclat Pharmaceuticals
- Developer Avadel Pharmaceuticals
- Class Analgesics; Antihypotensives; Decongestants; Propanolamines; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Beta-adrenergic receptor agonists; Central nervous system modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypotension